Ovid, part of Wolters Kluwer Health, US, has announced an agreement with Neural Regeneration Research (NRR), an English-language monthly medical journal, published in China. The agreement is part of Ovid’s ongoing efforts to strengthen its presence in China’s healthcare information market.
NRR is published by the publishing house of Neural Regeneration Research and China Science Press. The journal is sponsored by the Chinese Rehabilitation Medical Association and supervised by China’s Ministry of Health. Under the new deal, NRR will be available exclusively on OvidSP, via the OvidSP electronic search and discovery platform, to all Ovid customers globally.
Neural Regeneration Research (NRR) publishes original research and developments in the field of neuroregeneration, with contributions from experts in neuroanatomy, pathology, physiology, biochemistry, pharmacology, immunology and auxanology. Topics include the influences of neural stem cells, neuroengineering, neurodegeneration and traditional Chinese medicine and acupuncture intervention. The journal focusses on publishing meta-analysis articles with Chinese characteristics; evidence-based case clinical research articles; analysis of gene polymorphism related to region, nationality, and demography; review articles regarding new technology and new therapy; multi-center, large-sample, randomised, and controlled articles and reports; and more.
NRR will be accessible on OvidSP’s Journals@Ovid portal, which offers quick, easy access to about 1,200 premium and largely peer-reviewed journals in medicine and science—virtually none of which are embargoed. Users can search full-text articles via Journals@Ovid simultaneously with other e-resources for a streamlined, comprehensive search experience.
Search for more such discovery services in K-Store
Discuss this NEWS
